Literature DB >> 9091698

How safe is long-term prenatal glucocorticoid treatment?

J R Seckl1, W L Miller.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9091698

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

Review 1.  Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Authors:  C G Brook
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Pre-natal treatment of congenital adrenal hyperplasia and fetal malformations.

Authors:  N Ozbey
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

Review 3.  Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.

Authors:  D Merke; M Kabbani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  In utero intervention for urologic diseases.

Authors:  Douglass B Clayton; John W Brock
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

5.  Histochemical analyses of altered fetal lung development following single vs multiple courses of antenatal steroids.

Authors:  Zarah J Pua; Barbara S Stonestreet; Anne Cullen; Aliakbar Shahsafaei; Grazyna B Sadowska; Mary E Sunday
Journal:  J Histochem Cytochem       Date:  2005-06-13       Impact factor: 2.479

Review 6.  Prenatal treatment of congenital adrenal hyperplasia-not standard of care.

Authors:  Selma Feldman Witchel; Walter L Miller
Journal:  J Genet Couns       Date:  2012-05-26       Impact factor: 2.537

7.  Effects of low dose dexamethasone treatment on basal cardiovascular and endocrine function in fetal sheep during late gestation.

Authors:  Andrew J W Fletcher; Hugh H G McGarrigle; C Mark B Edwards; Abigail L Fowden; Dino A Giussani
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

8.  Ontogeny of adrenal steroid biosynthesis: why girls will be girls.

Authors:  Perrin C White
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  Experts' Opinion on the Prenatal Therapy of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency - Guideline of DGKED in cooperation with DGGG (S1-Level, AWMF Registry No. 174/013, July 2015).

Authors:  H G Dörr; G Binder; N Reisch; U Gembruch; P G Oppelt; P Wieacker; J Kratzsch
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

Review 10.  Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Felix G Riepe; Wolfgang G Sippell
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.